Cochrane · systematic review · CD004344

Treatment for avascular necrosis of bone in people with sickle cell disease

Martí‐Carvajal, AJ, Solà, I, Agreda‐Pérez, LH · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

Cystic Fibrosis and Genetic Disorders5 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Comparison

Population: patients with avascular necrosis in people with sickle cell disease
CD004344.PUB7 (current) · 3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain (
RR 0.95 [0.56, 1.6]1 study · 38 participantsVery low
Vaso‐occlusive crisis (
RR 1.14 [0.72, 1.8]1 study · 38 participantsVery low
Acute chest syndrome (
RR 1.06 [0.44, 2.56]1 study · 38 participantsVery low

Comparison

Population: patients with Avascular necrosis in people with sickle cell disease
CD004344.PUB6 · 3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain (
RR 0.95 [0.56, 1.6]1 study · 38 participantsVery low
Vaso‐occlusive crisis (
RR 1.14 [0.72, 1.8]1 study · 38 participantsVery low
Acute chest syndrome (
RR 1.06 [0.44, 2.56]1 study · 38 participantsVery low

Comparison

Population: patients with Avascular necrosis in people with sickle cell disease
CD004344.PUB5 · 3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain (
RR 0.95 [0.56, 1.6]1 study · 38 participantsVery low
Vaso‐occlusive crisis (
RR 1.14 [0.72, 1.8]1 study · 38 participantsVery low
Acute chest syndrome (
RR 1.06 [0.44, 2.56]1 study · 38 participantsVery low

Comparison

Population: patients with Avascular necrosis in people with sickle cell disease
CD004344.PUB4 · 3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain (
RR 0.95 [0.56, 1.6]1 study · 38 participantsVery low
Vaso‐occlusive crisis (
RR 1.14 [0.72, 1.8]1 study · 38 participantsVery low
Acute chest syndrome (
RR 1.06 [0.44, 2.56]1 study · 38 participantsVery low

Comparison

Population: patients with Avascular necrosis in people with sickle cell disease
CD004344.PUB3 · 3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain (
RR 0.95 [0.56, 1.6]1 study · 38 participantsVery low
Vaso‐occlusive crisis (
RR 1.14 [0.72, 1.8]1 study · 38 participantsVery low
Acute chest syndrome (
RR 1.06 [0.44, 2.56]1 study · 38 participantsVery low